SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

September 26, 2017

Primary Completion Date

September 30, 2022

Study Completion Date

December 31, 2027

Conditions
Autistic DisorderAutism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental DisordersMental DisordersAsperger's SyndromeNeurobehavioral ManifestationsNervous System Diseases
Interventions
DEVICE

SQUED™ series 28.1 home-use

"Semiconducting QUantum Excitonic Device - artifificial active medium, where the processes of self-organization lead to creation and converter of Autowaves energy.~Some autowaves have the properties of quasi-particles!"

Trial Locations (2)

40228

RECRUITING

World Autism Center, American Federation of Medical Synergetics, Department of Neurology; Cognitive Neurology/Neuropsychology WOMS, Louisville

81131

RECRUITING

Clinic of Synergetics, Department of Neurology; Cognitive Neurology/Neuropsychology of the World Organization of Medical Synergetics, Lviv

All Listed Sponsors
collaborator

Clinic of Synergetics, Department of Neurology/Neuropsychology WOMS

UNKNOWN

collaborator

Institute of Medical Synergetics, Department of Cognitive Neurology WOMS

UNKNOWN

collaborator

Laboratory of Neurocomputational Active Media WOMS

UNKNOWN

collaborator

SQUED, Inc., USA

UNKNOWN

collaborator

Center of Synergetics, Universität Stuttgart, Germany

UNKNOWN

collaborator

Ivan Franko National University of Lviv, Ukraine

UNKNOWN

collaborator

Danylo Halytsky Lviv National Medical University

OTHER

collaborator

World Organization of Medical Synergetics

OTHER

collaborator

World Autism Center, American Federation of Medical Synergetics

UNKNOWN

lead

American Federation of Medical Synergetics

OTHER